Literature DB >> 32472190

Enzymatically hardened calcium phosphate biocement with phytic acid addition.

Lubomir Medvecky1,2, Radoslava Stulajterova3, Maria Giretova3, Tibor Sopcak3, Zuzana Molcanova3, Karol Koval3.   

Abstract

Novel enzymatically hardened tetracalcium phosphate/monetite cements were prepared applying phytic acid/phytase (PHYT/F3P) mixture as hardening liquid after dissolving in acetic acid solution (CX cement). Properties of the cements were compared with classic cement hardened with 2% NaH2PO4 (C cement) and cement hardened with acetic acid solution (CAC cement) only. In the microstructure of CX cement, columnar growth of hydroxyapatite particles was found in the form of walls around hydroxyapatite agglomerates originated from tetracalcium phosphate which were mutually separated by a material depleted low density zone. Wet compressive strengths (CS) of all cements were practically identical contrary to about 30% higher dry CS's of CX and CAC cements due to specific microstructure. It was verified noncytotoxic character of CX cement extracts and positive effect of CX cement on ALP activity and cell behavior during cultivation. The final Ca/P molar ratio and setting time of cement were effectively controlled by the amount of phytic acid and the change in PHYT/F3P mass ratio, or reaction time in hardening liquid, respectively.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32472190     DOI: 10.1007/s10856-020-06387-5

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  1 in total

1.  Bioresorbable porous β-tricalcium phosphate chelate-setting cements with poly(lactic-co-glycolic acid) particles as pore-forming agent: fabrication, material properties, cytotoxicity, and in vivo evaluation.

Authors:  Akihiro Ando; Maho Kamikura; Yuko Takeoka; Masahiro Rikukawa; Kazuaki Nakano; Masaki Nagaya; Hiroshi Nagashima; Mamoru Aizawa
Journal:  Sci Technol Adv Mater       Date:  2021-06-24       Impact factor: 8.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.